Supermolecular inclusion of piroxicam with beta-cyclodextrin: a review of its pharmacological properties in laboratory animals

Lister, R.E.; Acerbi, D.; Cadel, S.

European Journal of Rheumatology and Inflammation 12(4): 6-11

1993


ISSN/ISBN: 0140-1610
PMID: 7805705
Document Number: 422019
Piroxicam-beta-cyclodextrin is a novel NSAID; it is a supermolecular inclusion complex designed to improve the risk:benefit ratio of piroxicam. In animal studies it has been shown to be as effective as piroxicam as an anti-inflammatory and analgesic agent but with a more rapid onset of action and reduced gastropathic effects.

Document emailed within 1 workday
Secure & encrypted payments